Connection
Joana Mack to Prognosis
This is a "connection" page, showing publications Joana Mack has written about Prognosis.
|
|
Connection Strength |
|
 |
|
 |
|
0.068 |
|
|
|
-
Verkamp B, Zoref-Lorenz A, Francisco B, Kieser P, Mack J, Blackledge T, Brik Simon D, Yacobovich J, Jordan MB. Early response markers predict survival after etoposide-based therapy of hemophagocytic lymphohistiocytosis. Blood Adv. 2023 12 12; 7(23):7258-7269.
Score: 0.039
-
Russ A, Mack J, Green-Murphy A, Occidental M, Mian A. Griscelli Type 2 Syndrome and Hemophagocytic Lymphohistiocytosis: Sisters With the Same Mutation but Different Presentations. J Pediatr Hematol Oncol. 2019 08; 41(6):473-477.
Score: 0.029